Ascentage Pharma Announces Series B Financing of RMB 500 Million to Advance Its Apoptosis-Targeted...

Ascentage Pharma, a global, clinical-stage biopharmaceutical company focused on apoptosis-targeted oncology drug discovery and development, has announced the completion of its Series B financing of RMB 500 million (equal to approximately $72...

“Every Client is a Partner” – ChinaBio® Interview

ChinaBio® recently had a chance to talk with Richard Soll, PhD, Senior Vice President of Integrated Services, Head of Corporate Alliances at WuXi AppTec, China’s largest contract research organization. The subject...

WuXI Global Webinar: “Accelerating Innovation in a Collaborative Biopharma Ecosystem”

Overview New avenues for innovation, productivity and efficiency are vital to bringing new medicines for global, unmet medical needs. Open innovation, open-access platforms, and partnership among industry, academia, non-profits, the venture capital...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Life Science Leaders Celebrate Global Partnerships During WuXi Global Forum 2018

More than 2,000 life science industry insiders around the globe participated in the WuXi Global Forum on Jan. 9, 2018 during the annual J.P....

WuXi Global Forum 2018